| For: | Zhao XQ, Zhu WJ, Mou Y, Xu M, Xia JX. Dupilumab for treatment of severe atopic dermatitis accompanied by lichenoid amyloidosis in adults: Two case reports. World J Clin Cases 2023; 11(10): 2301-2307 [PMID: 37122507 DOI: 10.12998/wjcc.v11.i10.2301] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i10/2301.htm |
| Number | Citing Articles |
| 1 |
Benedetta Tirone, Gerardo Cazzato, Francesca Ambrogio, Caterina Foti, Marco Bellino. Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic Option. Diseases 2024; 12(5): 94 doi: 10.3390/diseases12050094
|
| 2 |
Qin-Xiao Wang, Qian Ye, Kai-Yi Zhou, Si-Yu Luo, Sheng Fang. Systematic review and meta-analysis of treatments and outcomes in primary localized cutaneous amyloidosis. Clinical and Experimental Dermatology 2025; 50(7): 1343 doi: 10.1093/ced/llaf081
|
| 3 |
Rucha Janodia, Robert A. Schwartz. Cutaneous Amyloidosis: An Updated Approach Focusing on Macular Amyloidosis. Dermatology 2026; : 1 doi: 10.1159/000550263
|
| 4 |
Oksana A. Bitkina, Vera S. Murashova, Irina V. Temnova, Elena N. Derpaluk, Elizaveta V. Bitkina. Development of amyloid lichen in a patient with atopic dermatitis. Vestnik dermatologii i venerologii 2026; 101(6): 110 doi: 10.25208/vdv16893
|
| 5 |
Feiying Guo, Huajie Zhong, Yuan Wu, Xue Xu, Jiarong Tan, Qiang Zhou, Shunli Tang. Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature review. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1485079
|
| 6 |
Wenxin Zhang, Dandan Mao, Cheng Zhou, Guangdong Wen. Improvement of Low-Dose Abrocitinib-Resistant Lichen Amyloidosis with Dupilumab: Two Case Reports. Clinical, Cosmetic and Investigational Dermatology 2025; : 3087 doi: 10.2147/CCID.S555311
|
